22 June 2022
Events
Small Pharma to participate in the H. C. Wainwright 1st Annual Mental Health Conference on June 27, 2022
Small Pharma to participate in the H. C. Wainwright 1st Annual Mental Health Conference on…
Resources
Check out the latest news, press releases, events and insights or delve into all the content on specific topic areas such as DMT.
10 June 2022
Press Releases
Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
Small Pharma reports highlights for the fiscal year ended February 2022, including its financial results.
27 May 2022
Events
Small Pharma to present at the Jefferies Healthcare Conference in New York City on June 10, 2022
Small Pharma will present at the Jefferies Healthcare Conference in New York City on Friday…
25 May 2022
Press Releases
Small Pharma Shares Business Update Ahead of Annual Financial Results
Small Pharma shares business update ahead of annual financial results, including a new COO appointment.
5 May 2022
Events
Small Pharma to Participate in the PSYCH Symposium: London May 11, 2022
May 5th, 2022 – Small Pharma will participate in the PSYCH Symposium: London 2022 –…
27 April 2022
Events
Small Pharma To Present at the KCSA Psychedelics Virtual Investor Conference on April 28, 2022
April 27, 2022 – Small Pharma Inc. will present live at the KCSA Psychedelics Virtual…
20 April 2022
Insights
A brief history of DMT
DMT, short for N, N-Dimethyltryptamine, is a naturally-occurring, fast-acting psychoactive molecule. Also described as the…
5 April 2022
News
5 Most Important Psychedelic Clinical Trials in 2022
James Halifax, Psychedelic Spotlight writer and their resident psychedelic investor, recently covered his 5 most…
28 March 2022
News
DMT-Assisted Therapy May Address Root Cause of Major Depression
Gail Dutton of BioSpace.com, a leading online biotechnology source for breaking industry news and expert analysis,…
22 March 2022
News
Small Pharma CEO Peter Rand & CMSO Dr Carol Routledge at the 34th Annual Roth Conference
View Small Pharma’s Fireside Chat Webcast from the 34th Annual Roth Conference Monday, March 14 at 3:30…
TSXV:DMT
OTCQB:DMTTF
About Small Pharma
We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.
With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.